What is hydroxychloroquine used for usually?

Hydroxychloroquine (HCQ) is a medication that has been widely used for decades to treat various medical conditions. Originally developed as an antimalarial drug, it has since gained importance in managing autoimmune diseases and other health issues. In recent years, hydroxychloroquine has also been a topic of debate due to its potential use in treating viral infections.

Hydroxychloroquine sulfate is an antimalarial drug, which also has anti-inflammatory, immunomodulatory and anticoagulant effects. At present, hydroxychloroquine is mainly used in the clinical treatment of rheumatoid arthritis, juvenile chronic arthritis, discoid lupus erythematosus and systemic erythema Lupus, but the clinical onset is slow, and it usually takes 2 to 4 months.

Antimalarial Effect
Inhibit the metabolism of Plasmodium

Concentrated in the lysosomes of the malaria parasite, it raises the pH value, blocks the activity of heme polymerase → accumulation of toxic heme → death of the parasite.
Effective only for sensitive strains:
It is effective against chloroquine-sensitive Plasmodium (such as vivax malaria and terarium malaria), but ineffective against drug-resistant malaria.

Immune Regulation (Core Value)

Inhibit Toll-like receptor (TLR) signaling

Block TLR7/9 activation and reduce the release of inflammatory factors such as IFN-α and TNF-α (Nature Immunol, 2005).
Stable lysosomal membrane
Reduce the efficiency of antigen presentation and inhibit the activation of self-reactive T cells.
Interfere with calcium signals
Inhibit the expression of CD154 on T cells and block the activation of B cells.

Hydroxychloroquine Sulfate (HCQ) is an antimalarial drug used to treat systemic lupus erythematosus, rheumatoid arthritis and other autoimmune diseases, inflammation and skin diseases. It is also an inhibitor of autophagy and toll-like receptor (TLR) 7/9.

Autoimmune Disease

Systemic lupus erythematosus (SLE) : Control skin and joint lesions and reduce disease activity (SLEDAI score).

Rheumatoid arthritis (RA) : Relieves joint swelling and pain, and delays bone destruction (combined with methotrexate).
Sjogren's syndrome: Improves symptoms of dry mouth and dry eyes.

Prevention: Start taking it 1-2 weeks before entering malaria-endemic areas (400mg per week for adults).

Treatment: It is necessary to combine with other antimalarial drugs (such as chloroquine phosphate), and drug resistance is prone to occur when using a single drug.

Take during meals: Reduces gastrointestinal irritation.

Renal/liver insufficiency: Dosage adjustment is required (contraindicated when eGFR < 30ml/min).
Pediatric medication: For malaria prevention only (6.5mg/kg per week, not exceeding 400mg).

1.AFTER SALES

Effective reshi aftersales service

2.CUSTOMIZED

Customized Labelsand packageOEM /ODM service

3.STORAGE ROOM

USA warehouse

4.PRICE

Reasonablecompetitive price

The exact mechanisms vary depending on the condition:

For malaria: Disrupts parasite metabolism.

For autoimmune diseases: Suppresses overactive immune responses by interfering with cytokine production and immune cell signaling.

While generally safe when used correctly, HCQ requires medical supervision due to potential side effects:

Common side effects: Nausea, headache, dizziness, skin rashes.

Serious risks:

Eye damage (retinopathy): Long-term use requires regular eye exams.

Heart complications: Can cause QT prolongation (irregular heartbeats).

Hypoglycemia: May lower blood sugar levels, particularly in diabetics.

Hydroxychloroquine remains a valuable medication primarily for malaria, rheumatoid arthritis, and lupus. While it gained attention during the COVID-19 pandemic, its use for viral infections remains unsupported by strong evidence. Patients taking HCQ should do so under medical supervision to monitor for potential side effects.

If you have been prescribed hydroxychloroquine, always follow your doctor's instructions and report any unusual symptoms promptly. For those considering it for off-label uses, consult a healthcare professional to weigh the risks and benefits.

Would you like more details on any specific aspect of hydroxychloroquine? Let us know in the comments!

Alarcón, G. S., et al. (2007). Hydroxychloroquine use predicts complete remission in lupus patients. Arthritis & Rheumatism, 56(3), 876-881.

Kuhn, A., et al. (2016). Hydroxychloroquine in dermatology: Mechanisms and clinical applications. Journal of the American Academy of Dermatology, 74(2), 321-344.

Raoult, D., et al. (1999). Treatment of Q fever with hydroxychloroquine and doxycycline. Antimicrobial Agents and Chemotherapy, 43(4), 774-778.